Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis.

about

Palliative care during and following allogeneic hematopoietic stem cell transplantation.Severity, course, and predictors of sleep disruption following hematopoietic cell transplantation: a secondary data analysis from the BMT CTN 0902 trial.

P2860

Q50173239-2F023B16-A4FE-40C2-B5F4-2478D8732439 Q52689260-2CBF8D7D-5365-4EB5-9BC2-135C3AD6BFDF

P2860

Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis.

Item

http://www.wikidata.org/entity/Q40453749

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cancer and treatment distress ...... T CTN 0902 secondary analysis.

@en

type

Item

label

Cancer and treatment distress ...... T CTN 0902 secondary analysis.

@en

prefLabel

Cancer and treatment distress ...... T CTN 0902 secondary analysis.

@en

P1476

Cancer and treatment distress ...... T CTN 0902 secondary analysis.

@en

P2093

Heather S L Jim

http://www.w3.org/2001/XMLSchema#string

Jean C Yi

http://www.w3.org/2001/XMLSchema#string

Jennifer M Knight

http://www.w3.org/2001/XMLSchema#string

Karen L Syrjala

http://www.w3.org/2001/XMLSchema#string

Muneer H Abidi

http://www.w3.org/2001/XMLSchema#string

Stephanie J Lee

http://www.w3.org/2001/XMLSchema#string

Steven K Sutton

http://www.w3.org/2001/XMLSchema#string

William A Wood

http://www.w3.org/2001/XMLSchema#string

P2860

Delivering care to long-term adult survivors of hematopoietic cell transplantation.

Psychometric properties of the Cancer and Treatment Distress (CTXD) measure in hematopoietic cell transplantation patients.

Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.

Exercise and stress management training prior to hematopoietic cell transplantation: Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0902.

The assumption of a reliable instrument and other pitfalls to avoid when considering the reliability of data.

Screening for distress, the 6th vital sign: common problems in cancer outpatients over one year in usual care: associations with marital status, sex, and age.

Distress screening in allogeneic hematopoietic stem cell (HSCT) caregivers and patients.

Long-term health-related outcomes in survivors of childhood cancer treated with HSCT versus conventional therapy: a report from the Bone Marrow Transplant Survivor Study (BMTSS) and Childhood Cancer Survivor Study (CCSS).

Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature.

P304

1416-1423

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.30454

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

123

http://www.w3.org/2001/XMLSchema#string

P50

Paul B. Jacobsen

P577

2016-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27893933

http://www.w3.org/2001/XMLSchema#string

P932

5384862

http://www.w3.org/2001/XMLSchema#string

Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis.

about

P2860

P2860

Cancer and treatment distress psychometric evaluation over time: A BMT CTN 0902 secondary analysis.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932